<VariationArchive VariationID="100225" VariationName="NM_000552.5(VWF):c.2516del (p.Gly839fs)" VariationType="Deletion" Accession="VCV000100225" Version="7" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-07-29" DateCreated="2014-02-25" MostRecentSubmission="2021-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="106102" VariationID="100225">
      <GeneList>
        <Gene Symbol="VWF" FullName="von Willebrand factor" GeneID="7450" HGNC_ID="HGNC:12726" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12p13.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="5948877" stop="6124670" display_start="5948877" display_stop="6124670" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="6058039" stop="6233835" display_start="6058039" display_stop="6233835" Strand="-" />
          </Location>
          <OMIM>613160</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000552.5(VWF):c.2516del (p.Gly839fs)</Name>
      <CanonicalSPDI>NC_000012.12:6036417:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12p13.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="6036418" stop="6036418" display_start="6036418" display_stop="6036418" variantLength="1" positionVCF="6036417" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="6145584" stop="6145584" display_start="6145584" display_stop="6145584" variantLength="1" positionVCF="6145583" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>G839fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.6145585del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.6145585del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.6036419del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.6036419del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009072.2" sequenceAccession="NG_009072" sequenceVersion="2" change="g.93253del">
            <Expression>NG_009072.2:g.93253del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000552.5" sequenceAccession="NM_000552" sequenceVersion="5" change="c.2516del" MANESelect="true">
            <Expression>NM_000552.5:c.2516del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000543.3" sequenceAccession="NP_000543" sequenceVersion="3" change="p.Gly839fs">
            <Expression>NP_000543.3:p.Gly839fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_587" sequenceAccession="LRG_587">
            <Expression>LRG_587:g.93253del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_587t1" sequenceAccession="LRG_587t1">
            <Expression>LRG_587t1:c.2516del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_587p1" sequenceAccession="LRG_587p1" change="p.Gly839fs">
            <Expression>LRG_587p1:p.Gly839fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000552.3" sequenceAccession="NM_000552" sequenceVersion="3" change="c.2516delG">
            <Expression>NM_000552.3:c.2516delG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA228347" DB="ClinGen" />
        <XRef Type="rs" ID="61748481" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000552.5(VWF):c.2516del (p.Gly839fs) AND not provided" Accession="RCV000086616" Version="9">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000552.5(VWF):c.2516del (p.Gly839fs) AND multiple conditions" Accession="RCV001270518" Version="9">
        <ClassifiedConditionList TraitSetID="52393">
          <ClassifiedCondition DB="MedGen" ID="C1458140">Abnormal bleeding</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0040034">Thrombocytopenia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000552.5(VWF):c.2516del (p.Gly839fs) AND von Willebrand disease type 3" Accession="RCV001787048" Version="9">
        <ClassifiedConditionList TraitSetID="89">
          <ClassifiedCondition DB="MedGen" ID="C1264041">von Willebrand disease type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-01" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-02-01" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2014-02-25" MostRecentSubmission="2021-05-01">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <CitationText>www.varsome.com</CitationText>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <DescriptionHistory Dated="2019-09-28">
          <Description>not provided</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="89" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9627" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">von Willebrand disease type 3</ElementValue>
                <XRef ID="128108002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Von Willebrand disease, recessive form</ElementValue>
                <XRef ID="Von+Willebrand+disease%2C+recessive+form/7419" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Type 3 Von Willebrand's disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Type 3 VWD</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Von Willebrand disease, severe form</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">V WD3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VON WILLEBRAND DISEASE, TYPE III</ElementValue>
                <XRef Type="MIM" ID="277480" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VWD3</ElementValue>
                <XRef Type="MIM" ID="277480" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Von Willebrand disease (VWD), a congenital bleeding disorder caused by deficient or defective plasma von Willebrand factor (VWF), may only become apparent on hemostatic challenge, and bleeding history may become more apparent with increasing age. Recent guidelines on VWD have recommended taking a VWF level of 30 or 40 IU/dL as a cutoff for those diagnosed with the disorder. Individuals with VWF levels greater than 30 IU/dL and lower than 50 IU/dL can be described as having a risk factor for bleeding. This change in guidelines significantly alters the proportion of individuals with each disease type. Type 1 VWD (~30% of VWD) typically manifests as mild mucocutaneous bleeding. Type 2 VWD accounts for approximately 60% of VWD. Type 2 subtypes include: Type 2A, which usually manifests as mild-to-moderate mucocutaneous bleeding; Type 2B, which typically manifests as mild-to-moderate mucocutaneous bleeding that can include thrombocytopenia that worsens in certain circumstances; Type 2M, which typically manifests as mild-moderate mucocutaneous bleeding; Type 2N, which can manifest as excessive bleeding with surgery and mimics mild hemophilia A. Type 3 VWD (&lt;10% of VWD) manifests with severe mucocutaneous and musculoskeletal bleeding.</Attribute>
                <XRef ID="NBK7014" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17025" />
                <XRef ID="17025" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301765</ID>
                <ID Source="BookShelf">NBK7014</ID>
              </Citation>
              <XRef ID="166096" DB="Orphanet" />
              <XRef ID="C1264041" DB="MedGen" />
              <XRef ID="MONDO:0010191" DB="MONDO" />
              <XRef Type="MIM" ID="277480" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="52393" Type="Finding" ContributesToAggregateClassification="false">
            <Trait ID="31824" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Thrombocytopenia</ElementValue>
                <XRef ID="HP:0001873" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0002049" DB="MONDO" />
              </Name>
              <XRef ID="C0040034" DB="MedGen" />
              <XRef ID="D013921" DB="MeSH" />
              <XRef ID="MONDO:0002049" DB="MONDO" />
              <XRef Type="primary" ID="HP:0001873" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001906" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004838" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008175" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008268" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008302" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="22683" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Abnormal bleeding</ElementValue>
                <XRef ID="HP:0001892" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C1458140" DB="MedGen" />
              <XRef Type="primary" ID="HP:0001892" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004830" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004834" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004849" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004862" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004865" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008183" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1769639" SubmissionDate="2019-03-28" DateLastUpdated="2019-09-29" DateCreated="2019-09-29">
        <ClinVarSubmissionID localKey="c.2516delG_277480" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000899630" DateUpdated="2019-09-29" DateCreated="2019-09-29" Type="SCV" Version="1" SubmitterName="NIHR Bioresource Rare Diseases, University of Cambridge" OrgID="505998" OrganizationCategory="consortium" OrgAbbreviation="NIHR BR RD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">31064749</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <TypePlatform>Targeted sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">TGP0041</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.3:c.2516delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277480" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <StudyName>ThromboGenomics</StudyName>
        <SubmissionNameList>
          <SubmissionName>ThromboGenomics</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2864800" SubmissionDate="2020-09-19" DateLastUpdated="2020-12-19" DateCreated="2020-12-19">
        <ClinVarSubmissionID localKey="NM_000552.3:c.2516delG|HPO:HP:0001873;HP:0001892" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001450817" DateUpdated="2020-12-19" DateCreated="2020-12-19" Type="SCV" Version="1" SubmitterName="Birmingham Platelet Group; University of Birmingham" OrgID="500276" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.3:c.2516delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0001873" />
          </Trait>
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0001892" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8151378</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3096633" SubmissionDate="2021-04-15" DateLastUpdated="2021-05-01" DateCreated="2021-05-01">
        <ClinVarSubmissionID localKey="NM_000552.3:c.2516delG|OMIM:277480" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001572664" DateUpdated="2021-05-01" DateCreated="2021-05-01" Type="SCV" Version="1" SubmitterName="Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico" OrgID="507580" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-12">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <CitationText>www.varsome.com</CitationText>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.3:c.2516delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277480" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>Type 3 Von Willebrand International Registries Inhibitor Prospective Study (3WINTERS-IPS)</StudyName>
        <StudyDescription>The 3WINTERS-IPS aimed to assess number, types and risk factors for bleeding and the efficacy and safety of plasma-derived and/or recombinant Von Willebrand Factor concentrates used to treat type 3 VWD patients (ClinicalTrials.gov Identifier: NCT02460458)</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB9482148</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="209867" SubmissionDate="2012-07-31" DateLastUpdated="2014-02-25" DateCreated="2014-02-25">
        <ClinVarSubmissionID localKey="VWF_2515" />
        <ClinVarAccession Accession="SCV000118820" DateUpdated="2014-02-25" DateCreated="2014-02-25" Type="SCV" Version="1" SubmitterName="Academic Unit of Haematology, University of Sheffield" OrgID="500250" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.2:c.2515delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ISTH_VWFDB_2012_1_31</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3096633" TraitType="Disease" MappingType="XRef" MappingValue="277480" MappingRef="OMIM">
        <MedGen CUI="C1264041" Name="von Willebrand disease type 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2864800" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001892" MappingRef="HP">
        <MedGen CUI="C1458140" Name="Abnormal bleeding" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2864800" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001873" MappingRef="HP">
        <MedGen CUI="C0040034" Name="Thrombocytopenia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="209867" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1769639" TraitType="Disease" MappingType="XRef" MappingValue="277480" MappingRef="OMIM">
        <MedGen CUI="C1264041" Name="von Willebrand disease type 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

